Sign in

CIK 0001759425

  • Large accelerated filer

Mirum Pharmaceuticals, Inc.

Sign in to watch
Ticker
MIRM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831281555
Phone
+1 650-667-4085
Business address
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,138,950
in 5 filings, $4.8M under 10b5-1 plans

Net −$7,138,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-02 Longpre Lara CHIEF DEVELOPMENT OFFICER Sale −847 $26.19 $22K 104,407
2024-01-23 Longpre Lara CHIEF DEVELOPMENT OFFICER Grant or award · Stock Option (right to buy) +32,000 32,000
2024-01-23 Longpre Lara CHIEF DEVELOPMENT OFFICER Grant or award · Restricted Stock Units +8,000 8,000
2024-01-08 Longpre Lara CHIEF DEVELOPMENT OFFICER Sale −1,019 $28.04 $29K 105,254
2023-11-10 Longpre Lara Chief Development Officer Grant or award +434 $22.29 $10K 106,273
2023-07-03 Longpre Lara Chief Development Officer Sale −1,004 $25.65 $26K 105,839
2023-05-10 Longpre Lara Chief Development Officer Grant or award +684 $16.92 $12K 106,843
2023-01-31 Longpre Lara Chief Development Officer Grant or award +9,625 106,159
2023-01-31 Longpre Lara Chief Development Officer Grant or award · Stock Option (right to buy) +38,500 38,500
2023-01-09 Longpre Lara CHIEF DEVELOPMENT OFFICER Sale −1,003 $20.62 $21K 104,369
2019-09-10 Longpre Lara CHIEF DEVELOPMENT OFFICER Purchase +965 $10.64 $10K 105,372

Page 1 of 1 · 11 trades